Spaero Bio
AI NativeLab automation as flexible as your science
Est 2020|Valuation $20M|Raised $2M
Lab automation as flexible as your science
Published Aug 14, 2026
Spaero is listed in industry tool landscapes and event exhibitor lists, indicating visibility in the automation ecosystem and presence at industry events.
| Starting Price | Not public | Not public | Not public |
| Typical Fit | Labs seeking faster liquid-handler protocol iteration and operational constraints without bespoke code | Labs requiring orchestration/scheduling and integration services across instruments/workcells | Teams seeking abstraction for experiment design and integration of automation with digital biology workflows |
| Key Strength | Focus on rapid protocol design and runtime error handling features | Established orchestration offering with experience in regulated contexts and validated workcells | Emphasis on experiment abstraction and connectivity for optimization and design-of-experiments workflows |
| Key Weakness | Limited public proof points (limited public reviews; limited public security/compliance disclosures; unclear instrument coverage) | Deployments can be service-heavy and potentially overprovisioned for single-instrument use cases | May require significant enablement and integration effort; pricing and details often not transparent publicly |
—